Kansas ACC

The Official Twitter Account of the Kansas Chapter of the American College of Cardiology.

[Kansas ACC @KansasACC]

🏅 New in #JACCIMG: this state-of-the-art review is the first clinical reference document on #cvImaging considerations for Masters athletes—an important resource for evolving #SportsCardio care. https://t.co/qnWcoDX9Uw
@DermotPhelanMD

[Kansas ACC @KansasACC]

Catheter-based therapies are taking on a growing role in #PulmonaryEmbolism care. This article explores where they fit within the new guideline framework—and what that means for patient selection, timing, and treatment strategy. #JACC https://t.co/xxMwkIP92Y
#CathLab @GBarnesMD

[Kansas ACC @KansasACC]

ICYMI: Drs. John Spertus (@jspertus) and Harmony Reynolds unpack key insights from the #ACC26 HARP-Plus MINOCA study in a Quick Takes video on #ACCAnywhere. A useful watch for a fast take on the findings and their clinical relevance. 📹 https://t.co/xEpcVLrdUM
#CardioX

[Kansas ACC @KansasACC]

Despite fewer bleeding complications in high-risk #PulmonaryEmbolism, mortality has not improved—highlighting persistent challenges in caring for the sickest PE patients. Read more in #JACC: https://t.co/IWbBQDfiIF
@RosovskyRachel

[Kansas ACC @KansasACC]

Built for the whole CV care team, the 12th Annual Cardiovascular Symposium returns on October 24, 2026 at the Overland Park Convention Center. Save the date and plan to join colleagues from across Kansas. #KSACC #Cardiology

[Kansas ACC @KansasACC]

🧠💓 This month’s thoughtful #JACCBTS editorial page looks at several recent high-impact papers exploring how the nervous system and the heart are deeply intertwined. Read more from EiC Dr. @MatthiasNahrend and Dr. Kevin King: https://t.co/0oUQtOo0J0
#cvMI

[Kansas ACC @KansasACC]

🆕 #JACC Spotlight Issue puts acute #PulmonaryEmbolism guidance into a patient-centered journey—from risk factors and diagnosis to treatment, long-term management, and gaps that still need clarification. Worth a look across the full care continuum: https://t.co/0PZmucggUS

[Kansas ACC @KansasACC]

CV care in Asian populations calls for tailored approaches. New recommendations in this #JACCAsia study highlight key differences in risk and management—an important step toward more precise, population-specific care. https://t.co/xIDARChpYZ
#cvPrev #GlobalHealth

[Kansas ACC @KansasACC]

A day for the whole CV care team is coming this fall.

Save the date for the 12th Annual Cardiovascular Symposium on October 24, 2026 at the Overland Park Convention Center. More details to come. #KSACC #Cardiology

[Kansas ACC @KansasACC]

🍟 New MESA data at #ACC26 link higher ultraprocessed food intake to greater #ASCVD risk—with an even stronger association among Black Americans. Important findings at the intersection of diet, equity, and CV prevention. More: https://t.co/yrYXNSeuA2
#CardioX #JACCAdvances

[Kansas ACC @KansasACC]

Learn more about the SMART-DECISION trial and catch up on #ACC26 coverage here: https://t.co/Q5ea0tU8jS

[Kansas ACC @KansasACC]

@CaliforniaACC members are in Sacramento advocating for patients and smarter policy. ☀️ They’re urging lawmakers to streamline #PriorAuth for meds, stop automatic downcoding, and improve access to cardiovascular care. #ACCAdvocacy @JanetWeiMD @NikhilBassi

[Kansas ACC @KansasACC]

Looking to get more involved in advocacy? ACC members can take action through Action Alerts, the Advocate Checklist, legislator practice visits and more. You can also text ACC to 50457 for Action Alerts.

Learn more: https://t.co/SiY8XzvTx6

#KSACC #ACCAdvocacy

[Kansas ACC @KansasACC]

🫀 In childhood cancer survivors, daunorubicin (~0.6) and mitoxantrone (~10.5) showed CTRCD doses risk-equivalent to doxorubicin—helping refine cardiac surveillance. Evidence remains insufficient for epirubicin and idarubicin. https://t.co/yRfOK5lBLU
#JACCCardioOnc #cvPed

[Kansas ACC @KansasACC]

KSACC is offering travel scholarship support for 2 FITs to attend the ACC Legislative Conference in Washington, DC, Oct. 4 to 6, 2026. Each recipient will receive a $2,000 scholarship. Apply by Aug. 1 at [email protected].

#KSACC #ACCAdvocacy #Cardiology

[Kansas ACC @KansasACC]

🎧 In #EaglesEyeView, Dr. @keaglemd highlights key #ACC26 trials, including CHAMPION-AF, VESALIUS-CV, Ez-PAVE, PRO-TAVI + more. A strong listen for a quick roundup of practice-shaping science and standout meeting takeaways. 👉 https://t.co/CBPuZTjqsm

[Kansas ACC @KansasACC]

Save the date for the 12th Annual Cardiovascular Symposium on October 24, 2026 at the Overland Park Convention Center. Sessions will be designed for the whole CV care team. #KSACC #Cardiology

[Kansas ACC @KansasACC]

Why does a 1989 rule still shape physician payment today? #ACCAdvocacy is pushing to raise the budget neutrality threshold and reform the #MedicarePayment system. Send a message to lawmakers + hear from Drs. Scott Baumgartner & @KTamirisaMD: https://t.co/8XawfEqPEC

[Kansas ACC @KansasACC]

🍟🥤 New #ACC26 research: people consuming >9 servings/day of ultra-processed foods had a 67% higher risk of #MACE vs about 1 serving/day. Think chips, frozen meals, processed meats, sugary drinks, cereals, and breads. https://t.co/RklIdH4jfy
#JACCAdvances #ASCVD #CVD

[Kansas ACC @KansasACC]

📘 Prep smarter with ACC’s #ACHDSAP. Get insights from top #ACHD clinicians + board-focused, high-value content to support certification prep while strengthening day-to-day decisions and long-term outcomes.

Learn more 👉 https://t.co/NwrNOzAIYS
#ACCEd